Vejovine, a new antibiotic from the scorpion venom of Vaejovis mexicanus

Toxicon

Volumn 57, Issue 1, 2011, Pages 84-92

  Hernández Aponte, Cynthia A ^a   Silva Sanchez, Jesus ^b   Quintero Hernández, Verónica ^a   Rodríguez Romero, Adela ^c   Balderas, Cipriano ^a   Possani, Lourival D ^a   Gurrola, Georgina B ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Antibiotic; Multidrug resistant; Peptide; Scorpion; Vaejovis mexicanus

Indexed keywords

ANTIBIOTIC AGENT; SCORPION VENOM; UNCLASSIFIED DRUG; VEJOVINE;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG SYNTHESIS; ENTEROBACTER CLOACAE; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HOSPITAL INFECTION; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCORPION; VAEJOVIS MEXICANUS;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); ENTEROBACTER CLOACAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA; SCORPIONES; VAEJOVIS;

EID: 78650677487     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.10.008     Document Type: Article

References (41)

1. Aldhous M.C., Noble C.L., Satsangi J. Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease. PLoS One 2009, 4:e6285.
2. Bauer A.W., Kirby M. Antibiotic susceptibility testing by standardized single disk method. Am. J. Clin. Pathol. 1966, 45:493-496.
3. Bradshaw J. Cationic antimicrobial peptides: issues for potential clinical use. BioDrugs 2003, 17:233-240.
4. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 2005, 3:238-250.
5. Cerovský V., Hovorka O., Cvacka J., Voburka Z., Bednárová L., Borovicková L., Slaninová J., Fucík V. Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Chembiochem. 2008, 9:2815-2821.
6. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard 7th Edition 2006, vol. 26. Clinical and Laboratory Standards Institute, (2): pp. M7-A7.
7. Cole C., Barber J.D., Barton G.J. The Jpred 3 secondary structure prediction server. Nucleic Acids Res. 2008, 36:W197-W201.
8. Conde R., Zamudio F.Z., Rodríguez M.H., Possani L.D. Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 2000, 471:165-168.
9. Corzo G., Escoubas P., Villegas E., Barnhjam K.J., He W., Norton R.S., Nakajima T. Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator. Biochem. J. 2001, 359:35-45.
10. Dai C., Ma Y., Zhao Z., Zhao R., Wang Q., Wu Y., Cao Z., Li W. Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob. Agents Chemother. 2008, 52:3967-3972.
11. Dai L., Corzo G., Naoki H., Andriantsiferana M., Nakajima T. Purification, structure-function analysis, and molecular characterization of novel linear peptides from scorpion Opisthacanthus madagascariensis. Biochem. Biophys. Res. Commun. 2002, 293:1514-1522.
12. Ehret-Sabatiert L., Loew D., Goyffon M., Fehlbaum P., Hoffmann J., van Dorsselaer A., Bulet P. Characterization of novel cysteine-rich antimicrobial peptides from scorpion blood. J. Biol. Chem. 1996, 271:29537-29544.
13. Gao B., Rodriguez M.D., Lanz-Mendoza H., Zhu S. AdDLP, a bacterial defens in-like peptide, exhibits anti-plasmodium activity. Biochem. Biophys. Res. Commun. 2009, 387:393-398.
14. Garnier J., Gibrat J.F., Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol. 1996, 266:540-553.
15. Garza-Ramos U., Morfin-Otero R., Sader H.S., Jones R.N., Hernández E., Rodriguez-Noriega E., Sánchez A., Carrillo B., Esparza-Ahumada S., Silva-Sánchez J. Metallo-β-Lactamase gene, blaIMP-15, in a class 1 integron (In95) from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico. Antimicrob. Agents Chemother. 2008, 52:2943-2946.
16. Garza-Ramos U., Tinoco P., Rojas T., Carrillo B., Barajas J.M., Suárez S., Silva-Sanchez J. Molecular characterization of integron class 1 (in196) encoding the VIM-2 Metallo-β-lactamase of Pseudomonas aeruginosa isolated from a hospital environment. J. Chemother. 2009, 21:590-591.
17. Giuliani A., Pirri G., Bozzi A., Di Giulio A., Aschi M., Rinaldi A.C. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell. Mol. Life Sci. 2008, 65:2450-2460.
18. Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, a Public Health Crisis Brews 2004, Infectious Disease Society of America, Infectious Disease Society of America, Alexandria, VA, Available at. http://www.idsociety.org/WorkArea/showcontent.aspx%3Fid%3D5554.
19. Jenssen H., Hamill P., Hancock R.E.W. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19:491-511.
20. Karageorgopoulos D.E., Falagas M.E. New antibiotics: optimal use in current clinical practice. Int. J. Antimicrob. Agents 2009, 34S:S55-S62.
21. Kawasaki H., Iwamuro S. Potential roles of histones in host defense as antimicrobial agents. Infect. Disord. Drugs Targets 2008, 8:195-205.
22. Lee C. Therapeutic challenges in the era of antibiotic resistance. Int. J. Antimicrob. Agents 2008, 32(S4):S197-S199.
23. Lewis K., Ausubel F.M. Prospects for plant-derived antibacterials. Nat. Biotechnol. 2006, 24:1504-1507.
24. Merrifield B.R. Solid phase peptide synthesis I: the synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85:2144-2154.
25. Miranda G., Castro N., Leanos B., Valenzuela A., Garza-Ramos U., Rojas T., Solorzano F., Chihu L., Silva J. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum ß-lactamase in a Mexican pediatric hospital. J. Clin. Microbiol. 2004, 42:30-35.
26. Moerman L., Bosteels S., Noppe W., Willems J., Clynen E., Schoofs L., Thevissen K., Tytgat J., Van Eldere J., van der Walt J., Verdonck F. Antibacterial and antifungal properties of α-helical, cationic peptides in the venom of scorpions from southern Africa. Eur. J. Biochem. 2002, 269:4799-4810.
27. Paladino J.A. Linezolid: an oxazolidinone antimicrobial agent. Am. J. Health Syst. Pharm. 2002, 59:2413-2425.
28. Park K.H., Nan Y.H., Park Y., Kim J.I., Park I.S., Hahm K.S., Shin S.Y. Cell specificity, anti-inflammatory activity, and plausible bactericidal mechanism of designed Trp-rich model antimicrobial peptides. Biochim. Biophys. Acta 2009, 1788:1193-1203.
29. Pearson W.R., Lipman D.J. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. U S A 1988, 85:2444-2448.
30. Rodríguez de la Vega R.C., García B.I., D'Ambrosio C., Diego-García E., Scaloni A., Possani L.D. Antimicrobial peptide induction in the haemolymph of the Mexican scorpion Centruroides limpidus limpidus in response to septic injury. Cell. Mol. Life Sci. 2004, 61:1507-1519.
31. Silva E.C., Camargos T.S., Maranhão A.Q., Silva-Pereira I., Silva L.P., Possani L.D., Schwartz E.F. Cloning and characterization of cDNA sequences encoding new venom peptides of the Brazilian scorpion Opisthacanthus cayaporum. Toxicon 2009, 54:252-261.
32. Silva J., Estrada M.A., Garza-Ramos U., Lara R., Aguilar C., Ayala G., Ledezma L. TLA-1: a new plasmidic extended-spectrum ß-lactamase from Escherichia coli. Antimicrob. Agents Chemother. 2000, 44:997-1003.
33. Silva J., Gatica R., Aguilar C., Becerra Z., Garza-Ramos U., Velásquez M., Miranda G., Leaños B., Solórzano F., Echániz G. Outbreak of infection with extended-spectrum ß-lactamase producing Klebsiella pneumoniae in a Mexican hospital. J. Clin. Microbiol. 2001, 39:3193-3196.
34. Song Y., Lu Y., Wang L., Yang H., Zhang K., Lai R. Purification, characterization and cloning of two novel tigerinin-like peptides from skin secretions of Fejervarya cancrivora. Peptides 2009, 30:1228-1232.
35. Thomson J.D., Higgins D.G., Gibson T.J. Clustal W improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
36. Torres-Larios A., Gurrola G.B., Zamudio F.Z., Possani L.D. Hadrurin a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur. J. Biochem. 2000, 267:5023-5031.
37. Tytgat J., Chandy K.G., Garcia M.L., Gutman G.A., Martin-Eauclaire M.F., van der Walt J.J., Possani L.D. A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies. Trends Pharmacol. Sci. 1999, 20:444-447.
38. Velásquez-Meza M.E., Aires de Sousa M., Echaniz-Ávilez G., Solórzano-Santos F., Miranda-Novales G., Silva-Sánchez J., de Lencastre H. Surveillance of MRSA in a pediatric hospital in Mexico City during a seven year period (1997-2003), clonal evolution and impact of infection control. J. Clin. Microbiol. 2004, 42:3877-3880.
39. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
40. Zeng X.C., Wang S.X., Zhu Y., Zhu S.Y., Li W.X. Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch. Peptides 2004, 25:143-150.
41. Zhao Z., Ma Y., Dai C., Zhao R., Li S.R., Wu Y., Cao Z., Li W. Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob. Agents Chemother. 2009, 53:3472-3477.